Skip to content

DR.DE JAEGER ANN

Active
Private limited companyfounded 2008active for 18 yearsCapucienenlaan 35B, 9300 Aalst, BelgiumKBO/BCE: BE 0897.579.206
Summary

DR.DE JAEGER ANN has been active since 2008 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €680,124 and a net result of €129,750. Equity is growing by about 17% per year across the filed financial years. Its solvency ranks better than 89% of 20,604 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow ReportCompare
DR.DE JAEGER ANNActiveChecked score 96/100
Risk analysis ReportCompare

Overview

Activity
General medical practice
NACE 86210
1 site
Size
€725,600total assets 2025
Equity
€680,124
Profit
€129,750
Turnover not published (micro format)
Financial health
96 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2025 accounts 31 days early
Why 96lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 10.33, cash €327,064Equity €680,124 (93.7% of total assets)Figures for financial year 2025 (filed 30-06-2026)Show the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 70% of its sector peers (NACE 86, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Strong
Solvency 100=
equity 93.7% of total assets
Liquidity 100+37
short-term debt 6.0% · cash 45.1%
Profitability 91=
return on assets 17.9%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,117 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025highest value 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026lowest value 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value
Credit of up to €65,000 on 30-day terms is acceptable
Liquidity ample (current ratio 10.33, compared with 10.52 in 2024, above the usual 1.5; short-term debt: 6% and cash: 45.1% of total assets), and 6.3% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 95% on liquidity, 47% on profitability and 57% on growth.

The bankruptcy probability was computed on 24-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 10.33, cash €327,064
NBB · annual accounts
lowers risk · Equity €680,124 (93.7% of total assets)
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 30-06-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
31 days early
2024
on the day
2023
30 days late
2022
on the day
2021
22 days late
2020
26 days late
2019
28 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 11 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 31 July (5 of the last 5 filed years within 31 days of that day).
Companies Code · seven months
Where today falls in the filing period
25-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Highest result from 2018 to 2025net €129,750 ▲12.3%
  3. Annual accounts filedfinancial year 2024 · micro…

Key points

  • Positive: Among the best 11% on solvencysector median 63.0% · 20,604 companies 93.7% View
  • Positive: 8 profitable years in a rowprofit 2025: €129,750 8 years View
  • Total assets 20256 financial years filed €725,600 View

By topic

Financials

Financial year
2025
Total assets
€725,600
Profit
€129,750
Solvency
93.7%
Total assets▲ 10.8%
Net result
20182025
Go to Financials

Timeline

Events
23
Since
2009
Next accounts
by 31-07-2027
  1. 30-08-2024Annual accounts filed
  2. 29-02-2024Resignation: DE JAEGER Ann Emilia Elisabeth (manager)
  3. 31-07-2023Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
General medical practiceNACE 86210
Founded
28-04-2008
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
33
Annual meeting
Last Friday of June
Purpose
“De bevordering van de uitoefening van de geneeskunde door de arts-aandeelhouder met…” (deed in Dutch)
Go to Articles of association

Key facts about DR.DE JAEGER ANN

What is the company number of DR.DE JAEGER ANN?
0897.579.206. In Belgium the VAT number is the company number with BE in front: BE 0897.579.206.
Where is DR.DE JAEGER ANN based?
The registered office is at Capucienenlaan 35B, 9300 Aalst.Company details
What does DR.DE JAEGER ANN do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DR.DE JAEGER ANN?
Private limited company (BV).
When was DR.DE JAEGER ANN founded?
On 28-04-2008.
Is DR.DE JAEGER ANN still active?
Yes, DR.DE JAEGER ANN is an active enterprise in the KBO register.
How many employees does DR.DE JAEGER ANN have?
On average 1.1 full-time equivalents in financial year 2024, according to the filed annual accounts.Financials
What is the turnover of DR.DE JAEGER ANN?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is DR.DE JAEGER ANN profitable?
In financial year 2025, DR.DE JAEGER ANN made a profit of €129,750.
Where can I find the annual accounts of DR.DE JAEGER ANN?
DR.DE JAEGER ANN filed 18 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR.DE JAEGER ANN due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to DR.DE JAEGER ANN

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure